Slc38a10 is a novel regulator of osteoblastic bone formation
Main Authors: | Andrea S. Pollard, Davide Komla Ebri, Penny Sparkes, Apostolos Gogakos, John G. Logan, Natalie C. Butterfield, Victoria Leitch, J.H. Duncan Bassett, Graham R. Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Bone Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352187220300942 |
Similar Items
-
Mitoguardin-2 deficiency results in severe osteoporosis
by: Davide Komla-Ebri, et al.
Published: (2020-10-01) -
Functional validation of the osteoporosis GWAS candidate FUBP3 in knockout mice
by: Laura Watts, et al.
Published: (2020-10-01) -
Fgfr3 gain-of-function mutation impacts bone homeostasis in hypochondroplasia mouse model
by: Léa Loisay, et al.
Published: (2020-10-01) -
Nouvelles approches thérapeutiques pour l’achondroplasie
by: Komla-Ebri, Davide Selom Komi
Published: (2016) -
Characterization of solutecarrier SLC38A6
by: Al-walai, Somar
Published: (2012)